Companion Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Products and Services (Assays, Kits & Reagents, Software & Services), By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, Immunohistochemistry, Others), By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), Countries and Companies Report
Companion Diagnostics is projected to register a 10.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets